Since MDSCs are precursor myeloid cells with immunosuppressive and tumor-promoting capabilities [29], we also assessed the level of MDSCs (Gr-1+ CD11b+) in blood, spleen and tumor samples by flow cytometry analysis. The gene discussed is ITGAM; the disease is neoplasm.